Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
4
×
clinical trials
life sciences
national blog main
national top stories
new york blog main
new york top stories
gene therapy
san francisco blog main
san francisco top stories
fda
hemophilia
johnson & johnson
new york
novartis
pfizer
spark therapeutics
zolgensma
10x genomics
abbvie
achromatopsia
allergan
amgen
anemia
antibiotic
astrazeneca
autism
autism spectrum disorder
avexis
beta-thalassemia
bill cassidy
biogen
biomarin
biotech
bluebird bio
boulder/denver blog main
boulder/denver top stories
brian kaspar
bristol-myers squibb
What
past
4
×
gene
therapy
age
aim
august
bigger
biggest
bio
biotech
boost
busy
cancer
change
close
come
community
data
days
deal
decisions
devices
diagnostics
docs
drugs
emerging
fda
flatiron
forward
gave
heated
helped
hemophilia
immunotherapy
j
johnson
legacy
market
medical
medicines
Language
unset
Current search:
past
×
" boston top stories "
×
@xconomy.com
5 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
With Data, Pfizer/Sangamo Step Forward in Hemophilia Gene Therapy Race
@xconomy.com
5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy
@xconomy.com
6 years ago
With OneOncology, Flatiron and Cancer Docs Aim to Boost Community Care